摘要
目的研究肝硬化患者血ChE活性变化以及PA检测临床意义。方法 25例肝硬化患者与40例非肝病患者分别为观察组及对照组,检测血清ChE与PA。结果肝硬化组血清ChE与PA明显降低,故血清ChE与PA能敏感反映肝细胞损害程度,其变化对肝硬化的诊断和病情观察是一项有特色的指征之一。结论测定PA、ChE两者水平可以作为肝硬化患者病情监测的有效指标。
Objective To study the serum ChE activity in cirrhosis patients and clinical significance of detection of PA.Methods 25 cases and 40 cases of non-cirrhotic patients with liver disease were observed as case group and control group,examined their serum ChE and PA.Results Cirrhosis serum ChE and PA significantly reduced obviously,We could think that the Serum ChE and PA is a reflection of a sensitive indicator of liver cell damage,It could evaluate hepatic functional reserve,and we could use it to understand the disease and prognosis.Conclusion The PA, ChE levels in patients with cirrhosis can be used as an effective indicator of disease surveillance.
出处
《中国药物经济学》
2013年第S3期171-,529,共2页
China Journal of Pharmaceutical Economics
关键词
肝硬化
胆碱酯酶
血清前白蛋白
Cirrhosis of the liver
Cholinesterase
Prealbumin
